Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 0.00 is 100% below its 4-year average of 0.00, near the high end of its 4-year range (-0.63–0.01).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00.
DEBT TO EQUITY RATIO
0.00
DEBT TO EQUITY RATIO AVG TTM
0.00
DEBT TO EQUITY RATIO AVG 3Y
0.00
DEBT TO EQUITY RATIO AVG 5Y
N/A
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
-100.00%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.12
median of 647 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Cadrenal Therapeutics, Inc. Common Stock
Market Cap
$3.26M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
N/A
Market Cap
$3.39M
Debt to Equity Ratio
7.21
TTM Avg
1.21
3Y Avg
0.62
5Y Avg
0.62
Market Cap
$3.33M
Debt to Equity Ratio
0.07
TTM Avg
0.10
3Y Avg
0.11
5Y Avg
0.08
Market Cap
$3.53M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.04
5Y Avg
0.04
Market Cap
$3.23M
Debt to Equity Ratio
0.02
TTM Avg
0.06
3Y Avg
0.17
5Y Avg
0.12
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cadrenal Therapeutics, Inc. Common Stock (CVKD) | $3.26M | 0.00 | 0.00 | 0.00 | N/A |
| Moolec Science S.A. (MLEC)vs › | $3.39M | 7.21 | 1.21 | 0.62 | 0.62 |
| Evogene Ltd. (EVGN)vs › | $3.51M | N/A | 0.69 | 0.37 | 0.26 |
| Aethlon Medical, Inc. (AEMD)vs › | $3.33M | 0.07 | 0.10 | 0.11 | 0.08 |
| Eocene Ltd. (EOCN)vs › | $3.48M | N/A | N/A | N/A | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 0.00 | 0.00 | 7.00 | 4.21 |
| Nexalin Technology, Inc. (NXL)vs › | $3.53M | 0.00 | 0.00 | 0.04 | 0.04 |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.23M | 0.02 | 0.06 | 0.17 | 0.12 |
| MBody AI Ltd. (MBAI)vs › | $3.21M | 0.00 | 0.00 | 0.01 | 0.01 |
| IceCure Medical Ltd (ICCM)vs › | $3.15M | 0.01 | 0.05 | 0.04 | 0.04 |
Debt/Equity
0.00
Current Ratio
3.73
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | 0.00 |
| 2026-03-31 | 0.00 |
| 2025-12-31 | 0.00 |
| 2025-09-30 | 0.00 |
| 2025-06-30 | 0.00 |
| 2025-03-31 | 0.00 |
| 2024-12-31 | 0.00 |
| 2024-09-30 | 0.00 |
| 2024-06-30 | 0.00 |
| 2024-03-31 | 0.00 |
| 2023-12-31 | 0.00 |
| 2023-09-30 | 0.00 |
| 2023-06-30 | 0.01 |
| 2023-03-31 | 0.01 |
| 2022-12-31 | -0.12 |
| 2022-09-30 | -0.45 |
| 2022-06-30 | -0.63 |
| 2022-03-31 | 0.00 |
